SFM
AMRX icon

Systematic Financial Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Systematic Financial Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-63,395
Closed -$302K – 257
2020
Q2 		$302K Sell
63,395
-47,185
-43% -$194K 0.02% 370
2020
Q1 		$385K Sell
110,580
-39,115
-26% -$166K 0.02% 233
2019
Q4 		$722K Buy
+149,695
New +$520K 0.03% 189

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Systematic Financial Management's AMRX Position: Q3 2020 in Review

Systematic Financial Management sold out of Amneal Pharmaceuticals (AMRX) in Q3 2020, closing a stake of 63,395 shares — an estimated $302K sold.

Systematic Financial Management first reported a position in AMRX in Q4 2019 and held it in 3 quarters. The position peaked at $722K in Q4 2019. 140 funds tracked by Wall St. Rank hold AMRX as of Q3 2020.

  • Systematic Financial Management reported no remaining Amneal Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 63,395 Amneal Pharmaceuticals shares in Q3 2020, an estimated $302K.
  • Systematic Financial Management first reported a position in Amneal Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Systematic Financial Management's Amneal Pharmaceuticals position peaked at $722K in Q4 2019.
  • 140 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.